Autoimmunity Reviews

Article	Citations
“Fibromyalgia syndrome” related to Essure devices	297
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	185
Editorial Board	152
Editorial Board	133
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	114
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	109
Editorial Board	94
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	89
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	86
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	80
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	79
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	76
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	75
Susac syndrome: A scoping review	75
Endometriosis and autoimmunity	75
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	73
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome	73
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	72
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	71
Editorial Board	69
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	69
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	63
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	62
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 24	61
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	60

Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	55
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	54
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	53
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	53
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	52
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	52
Can anticoagulation be withdrawn in APS patients after aPL negativization?	50
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	50
Autoimmunity in vitiligo: Therapeutic implications and opportunities	49
Psychiatric manifestations of autoimmune encephalitis	47
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	45
Seronegative autoimmune diseases: A challenging diagnosis	45
Autoimmune pre-disease	45
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	44
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	43
A descriptive study of IgG4-related disease in children and young adults	42
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	42
Editorial Board	42
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	42
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	42
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	42
Editorial Board	41
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	40
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	39
Adipose failure through adipocyte overload and autoimmunity	39
SpA plus IBD or IBD plus SpA: Does commutative property apply?	39
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	39
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	38
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	38
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	37
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	37
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	37
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	36
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	36
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database	36
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	36
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	35
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases	35
Editorial Board	35
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	34
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	34
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	34
Fibromyalgia: Are we using the biopsychosocial model?	34
Chronic inflammation in Long COVID relationship to autoimmune diseases	33
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	33
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	31
The role of mitochondrial dysfunction in kidney injury and disease	31
Development of an algorithm for IgG4-related disease management	30
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	30
The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function	30

Tumor necrosis factor-α inhibitor-related autoimmune disorders	30
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	29
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	29
Reply letter to letter to the editor	28
Are IF-ANA the guiding light for SLE classification in the real-world setting?	28
Editorial Board	28
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	27
Twenty shades of the mosaic of autoimmunity	27
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	27
Editorial Board	27
Editorial Board	27
Alarmins in autoimmune diseases	27
Anti-rods/rings autoantibodies in a patient with pancreatic injury	27
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	27
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	26
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	26
Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis	26
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy	26
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	26
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	26
Mucous membrane pemphigoid	26
In Memoriam: Pierre Youinou	25
Neuroimaging in thyroid eye disease: A systematic review	25
Cutting edge confusion about cut-off settings in autoimmune diagnostics	25
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	25
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	24
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	24
Editorial Board	24
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	24
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	24
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	24
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	24
Serum calprotectin is a marker of disease activity in Giant cell arteritis	23
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	23
Diagnostic approach in giant cell arteritis	23
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	23
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	23
Editorial Board	23
Is it time for treat-to-target in antiphospholipid syndrome?	22
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	22
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	22
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	22
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	22
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	22
Inflammatory muscle involvement in systemic vasculitis: A systematic review	21
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	21
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	21
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	21
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	21
Salivary gland involvement in ANCA-associated vasculitis	21
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	21
Don't mix apples and oranges. Reply to Azoulay et al.	21
Persistent aortic inflammation in patients with giant cell arteritis	21
JAK inhibitors and systemic sclerosis: A systematic review of the literature	21
Editorial Board	21
From inflammation to renal fibrosis: A one-way road in autoimmunity?	21
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	20
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	20
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	20
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	20
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	20
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	20
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	20
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	20
Editorial Board	20
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	20
Intermittent fasting: A promising dietary intervention for autoimmune diseases	19
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	19
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	19
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	19
Rapid radiographic progression in rheumatoid arthritis: Definition, prediction and treatment	19
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	19
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	18
Involvement of aquaporin 5 in Sjögren’s syndrome	18
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	18
Insights into new-onset autoimmune diseases after COVID-19 vaccination	18
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis	18
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	18
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	18
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	17

Anti-glomerular basement membrane vasculitis	17
Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis	17
Prevention of rheumatoid arthritis using a familial predictive medicine approach	17
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	17
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	17
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations	17
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	17
Emerging roles of mechanically activated ion channels in autoimmune disease	17
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	17
Editorial Board	17
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	17